Liarozol

Liarozol
Ogólne informacje
Wzór Hilla

C17H13ClN4

Masa molowa

308,77 g/mol

Identyfikacja
Numer CAS

115575-11-6

PubChem

60652

DrugBank

DB13066

Liarozolorganiczny związek chemiczny, niesteroidowy inhibitor aromatazy, blokujący metabolizm kwasu retinowego. Może być alternatywą dla ogólnoustrojowej terapii retinoidowej u pacjentów z rybią łuską blaszkowatą[1].

Przypisy

  1. A. Vahlquist i inni, Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: Results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial, „The British Journal of Dermatology”, 170 (1), 2013, s. 173–181, DOI10.1111/bjd.12626, PMID24102348, PMCIDPMC4232915 (ang.).

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
Kembali kehalaman sebelumnya